The Global Pandemic Industrial Complex

By Thirty Pieces of Silver with Tom Littleton, 13 May, 2021

In 2020 the world had its first glimpse of the modern day Pandemic Industrial Complex in action as the Covid -19 report spread throughout the world. It is fair to say that life has yet to return to normal and for some powers behind this GLOBAL effort -it never will again. Hoards of funding and powerful entities like the World Economic Forum,The World Bank, The World Health Organization have seen the pandemic and the economic impact of it as the "last great chance" for mankind ,for a "Great Reset" of the global economy for a "more equitable world" and for saving the planet from "Global Warming". (See World Economic Forum :The Great Reset for more information and the talking points).

What became obvious in 2020 was that the Pandemic Industrial Complex (PIC) is Global. It is a well established network with far reaching powers. Using the health care systems of the United Nations and individual nations ,a network of controls and mandated restrictions descended over the plant and remain a year +later for much of the population. Behind PIC is the funding of billionaire activist and the freshly printed spending of the United States and other developed nations.The end game on the surface, according to the talking points, is stemming the spread of a deadly disease but the broader talking points reveal a deeper and more disturbing set of realities including long term plans of travel restrictions, economic redistribution, and mandated vaccines .The uncertain, politically driven and questionable science behind the work of the Pandemic Industrial Complex has made even some of the most submissive /anti conspiracy theorist question it. Still through the help of censorship from social media and a complicit and owned global media outlets the FEAR inspiring news of the "deadly Covid -19 outbreak" and mutated variants move forward to the ends of the earth with daily doses of terror inspiring updates.

A LOOK INSIDE THE PANDEMIC INDUSTRIAL COMPLEX

https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2018/181009-gcbr-tech-report.pdf

"Technologies To AddressGlobal Catastrophic Biological Risks"

"John Hoipkins Center for Health Security "Bloomberg School of Health "

Projects like - "Event 201" Oct 2019 Pandemic mock- through plan

with fake news media - fake health officials - fake political and corporate

and even faith leader responses .WEF ,Gates Foundation and Microsoft at Event 201:A Facebook Co Founder provided funding for John Hopkins Center

.THE PLAYERS AT THE TABLE OCTOBER 2019

"Eric Toner, MD, is the exercise team lead from the Johns Hopkins Center for Health Security. Crystal Watson, DrPH, MPH and Tara Kirk Sell, PhD, MA are co-leads from the Johns Hopkins Center for Health Security. Ryan Morhard, JD, is the exercise lead from the World Economic Forum, and Jeffrey French is the exercise lead for the Bill and Melinda Gates Foundation."

SOME OF THE FUNDING

Open Philanthropy Project-" Our main funders are Cari Tuna and Dustin Moskovitz, a co-founder of Facebook and Asana"

$16 million dollar grant to John Hopkins - Event 201 detailed the suppression of free speech on social media and internet as "controlling misinformation "

2019 grant $19,500,000

https://www.openphilanthropy.org/focus/global-catastrophic-risks/biosecurity/center-health-security-biosecurity-health-security-gcrs-2019

Johns Hopkins Center for Health Security — Biosecurity, Global Health Security, and Global Catastrophic Risks (2019)

Organization Name

Johns Hopkins Center for Health Security

Award Date

9/2019

Grant Amount

$19,500,000

Purpose

"To support work on biosecurity and global catastrophic risks posed by pathogens"

"The Open Philanthropy Project recommended a grant of $19,500,000 over three years to the Johns Hopkins Center for Health Security (CHS) to support work on biosecurity, global catastrophic risks posed by pathogens, and other work related to CHS’s mission, and to support the Emerging Leaders in Biosecurity Initiative. CHS plans to use these funds to continue to conduct policy research and continue to build communications and advocacy capacity."

"This follows our October 2016 and January 2017 support , and falls within our focus area of biosecurity and pandemic preparedness."

DETAILS OF THE COMING MESSIANIC ROLE OF PANDEMIC INDUSTRIAL COMPLEX

Details from new document

"Major pandemic risks and global catastrophic biological risks are important and extraordinary challenges. The results of this analysis show that there are technologies that can be harnessed to respond to major pandemics and GCB events"

A vision for ubiquitous sequencing

https://genome.cshlp.org/content/25/10/1411.full

Health-related applications

Real-time DNA sequencing has remarkable potential for diagnosing infectious diseases by bringing the sequencers to at-risk individuals. For example, rapid sequencing at airport checkpoints might be useful to control pathogen outbreaks and offer medical assistance to affected passengers.- also in home appliances even "SMART" toilets."

OVERVIEW OF FOCUS AREAS

" Disease Detection, Surveillance, and Situational Awareness Ubiquitous Genomic Sequencing and Sensing: As a surveillance tool, ubiquitous sequencing would allow for the near-real-time characterization of pathogen biology, including determinations of virulence, transmissibility, and sensitivity or resistance to medicines or vaccines."

"Drone Networks for Environmental Detection: Networks of land-, sea-, and air-based drones autonomously conducting environmental surveillance would be one way to help fill gaps in monitoring of the environment for biological disruption to important ecosystems and bioterrorism events. Drones can traverse different ecosystems to collect data using a variety of sensors and tools, ranging from optical cameras to complex biotechnology."

"Remote Sensing for Agricultural Pathogens: Advanced satellite imaging and image processing technologies can be used for ongoing, widespread, systematic agricultural surveillance to monitor the health of important crops and other vegetation in order to detect potential threats before they become widespread"

"Infectious Disease Diagnostics Microfluidic Devices: Microfluidic devices are “lab on a chip” diagnostic devices that have the potential to augment or replace traditional laboratory testing equipment in some contexts, thus making diagnostics more accessible, usable, and useful at the bedside and in resource constrained environments."

"Handheld Mass Spectrometry: The future of mass spectrometry is a handheld, truly portable unit that can provide advanced diagnostic capabilities in the field and at the point of care. Some mass spectrometry technologies may even provide pathogen-agnostic or pan-domain diagnostic capability, eliminating the need to even differentiate among bacteria, viruses, fungi, or protozoa before conducting diagnostic tests."

"Cell-Free Diagnostics: Cell-free diagnostics do away with the cell membrane to use the machinery within bacterial cells in combination with engineered genetic circuits to make proteins for diagnostic purposes. These cell-free diagnostics can generate rapid colorimetric outputs visible to the naked eye for easy interpretation. The cell extracts can also be freeze-dried onto paper for use in austere environments."

"Distributed Medical Countermeasure Manufacturing 3D Printing of Chemicals and Biologics: 3D pharmaceutical printing could be used for distributed manufacturing of MCMs as well as personalized drug dosing and formulations. 3D printers now have the capacity to synthesize key chemicals and pharmaceuticals almost anywhere a printer can go, and work is also under way to explore use of this technology to print vaccines."

"Synthetic Biology for Manufacturing MCMs: Synthetic biology provides the opportunity for novel approaches to both finding and producing therapeutics, as well as the capability of producing these therapeutics in a distributed and tailored way. This could mean that drugs and vaccines are discovered more quickly and produced much faster and in much larger quantities than is possible with traditional manufacturing techniques."

"Medical Countermeasure Distribution, Dispensing, and Administration Microarray Patches for Vaccine Administration: The microarray patch (MAP) is an emerging vaccine administration technology that has the potential to modernize the conduct of mass vaccination campaigns. The widespread adoption of MAP technology would significantly decrease a population’s time to complete immunization operations by enabling self-administration during emergencies."

"Self-Spreading Vaccines: Self-spreading vaccines are genetically engineered to move through populations like communicable diseases, but rather than causing disease, they confer protection. The vision is that a small number of individuals in a target population could be vaccinated, and the vaccine strain would then circulate in the population much like a pathogenic virus, resulting in rapid, widespread immunity"

"Ingestible Bacteria for Vaccination: Bacteria can be genetically engineered to produce antigens in a human host, acting as a vaccine, which triggers immunity to pathogens of concern. These bacteria can be placed inside capsules that are temperature stable, and they can be self-administered in the event of a pandemic."

"Self-Amplifying mRNA Vaccines: SAM vaccines use the genome of a modified virus with positive sense RNA, which is recognizable to our human translational machinery. Once delivered inside a human cell, the SAM is translated and creates 2 proteins: an antigen of interest to stimulate an immune response, and a viral replicase for intracellular amplification of the vaccine. The ability of SAM to self-replicate results in a stronger, broader, and more effective humoral and cellular immune response than some other vaccines."

" Drone Delivery to Remote Locations: Drone transportation networks can enable the rapid delivery of clinical materiel and pharmaceutical supplies to areas that are difficult to access, either due to physical or topographical barriers or the risk of infection for human responders."

"Medical Care and Surge Capacity Robotics and Telehealth: Robotics and telehealth are 2 broad categories of healthcare technologies that may be relevant during the medical response to a GCB event. Successful use of these technologies during such an event would facilitate medical care in nontraditional environments like the home."

"Portable, Easy-to-Use Ventilator: In a severe outbreak of respiratory disease, ventilators will be needed for the sickest patients to support breathing during the worst of their illness and while they recover. The availability of an inexpensive, portable mechanical ventilator with an intuitive and largely automated user interface could allow for the care and survival of many more patients than would be possible if a pandemic emerged today."

EMERGING DEVELOPMENT TECHNOLOGIES

“Cell Free Technology diagnostics and development

What is This technology? Cell-free diagnostics harness the power of engineered genetic circuits and bring them out of the lab and into the field using freeze-dried cell-free extracts.22Synthetic biology methods traditionally have been carried out in living cells.”

Genetically engineered strains of Bacterial Organisms

What is This technology? Genetically engineered strains of bacterial organisms, such as yeast and salmonella, can increasingly be programmed to manufacture many kinds of useful products, including drugs and vaccines.26 Synthetic biology takes advantage of the fact that bacterial biosynthetic pathways have natural built-in modularity, meaning they can be edited and re-ordered to customize the products being produced by bacterial cells.

Vaccine DELIVERY - new technologies

Medical Countermeasure Distribution, Dispensing, and Administrations"

microarray patches for vaccine administration

WHAT IS THIS TECHNOLOGY?

"A microarray patch (MAP; also called a microneedle patch) is an emerging technology for administering vaccines that has the potential to modernize mass vaccination campaigns. MAPs have been proposed for use against measles, influenza, and other infectious diseases and could theoretically be developed for most vaccine-preventable diseases. Currently, MAPs are being evaluated by the CDC and PATH for global health applications, but they could be highly useful in emergency response settings as well"